Who We Are
Bora Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in complex oral solid dosage (tablet & capsules), biologics, liquids (solutions, suspensions, ophthalmics & nasal sprays), powders, semi-solids (creams, ointments & gels), and sterile injectables for pharmaceutical products for Clinical through Commercial manufacturing and packaging.
Our Facilities
Bora owns and operates ten state-of-the-art CGMP manufacturing facilities (Taiwan, Canada, and the US) built to the highest international standards for manufacturing, packaging, R&D, and analytical testing.
Our Taiwanese facilities are USFDA, MHRA, TFDA, Jordan FDA, and GCC (Gulf Cooperation Council) inspected. Our Mississauga, Canada site is approved by all major regulatory agencies including USFDA, Health Canada, ANVISA, EMEA, PDMA, and the Japanese Ministry of Health. Our last FDA audits have had no 483s.
Global Presence
Our sites deliver to more than 100 markets around the world including the US/Canada, EU, Southeast Asia, Middle East, and South and Central Americas. All sites are TAA compliant. Our packaging lines are fully serialized.
Bora Pharmaceuticals is publicly traded on the Taiwan Stock Exchange (6472.TW) with an extremely solid financial foundation and experienced management team.
Bora has the capacity, resources, and highly experienced teams capable of delivering the flexibility and quality pharma needs to see their innovations swiftly and successfully to market.
Our mission
At Bora, our defining mission is to provide our customers with the unparalleled quality, flexibility, experience, and client service they need to effectively and efficiently reach program goals for their drug products. To meet those priorities, Bora’s teams, technologies, and facilities stand ready to deliver MAKING SUCCESS MORE CERTAIN.
